U.S. Healthtech Stock News

Dutch Bros (BROS) is back in focus after reporting adjusted earnings per share of US$0.17 against forecasts of US$0.09, alongside record revenue and same store sales growth, while issuing cautious 2026 same store sales guidance. See our latest analysis for Dutch Bros. The share price reaction tells a mixed story, with a 1 day share price return of 5.56% after earnings but a year to date share price return of 18.50% decline, while the 3 year total shareholder return of 57.33% points to...

For investors wondering whether Amazon.com is fairly priced at around US$208 per share or if the market is missing something, this article explains what the current valuation signals may be indicating. The stock has been relatively flat over the past month with a 0.1% decline. It still shows a 6.3% return over the last year and a 106.0% return over three years, which may raise questions about whether the recent share price reflects its longer term performance. Recent headlines have focused...

Broadstone Net Lease (BNL) has drawn investor attention after recent share price moves, with the stock closing at $18.27 and showing mixed returns over the past week, month, and past 3 months. See our latest analysis for Broadstone Net Lease. While the 1 day and 1 month share price returns of 1.67% and 5.78% declines point to some cooling in the near term, the 90 day share price return of 5.18% and 1 year total shareholder return of 14.25% suggest momentum has built over a longer stretch as...

Why Waste Management’s renewable gas push matters now Waste Management (WM) is pouring billions into 20 renewable natural gas plants, a shift that puts regulatory trends, ESG mandates, and carbon credit markets in clearer focus as the upcoming earnings release approaches. See our latest analysis for Waste Management. Despite the upcoming earnings focus and the renewable gas build out, WM’s recent price action has been mixed, with a 4.6% 30 day share price decline but a 47.1% three year total...

Proto Labs (PRLB) is back in focus after reporting record quarterly revenue, 12.1% year over year revenue growth, and earnings that came in ahead of market expectations, along with guidance that topped EPS forecasts. See our latest analysis for Proto Labs. Despite the upbeat earnings news, Proto Labs has had a mixed share price run, with a 12.71% 90-day share price return and an 11.04% year-to-date share price return. The 1-year total shareholder return sits at 61.12% and the 3-year total...

If you are wondering whether Masimo at around US$177.87 is offering value or asking you to pay up for quality, this breakdown will help you frame that question clearly. The stock has been relatively steady over the last week with a 0.5% decline, modestly higher over 30 days with a 1.4% gain, and much stronger year to date with a 39.6% return, compared with a 6.1% return over the past year and a 24.2% decline over five years. Recent headlines have focused on Masimo's position in medical...

Volvo Cars has converted its outstanding shareholder loans to Polestar Automotive Holding UK (NasdaqGM:PSNY) into equity, changing the mix of Polestar’s capital structure. The two companies also agreed to concentrate future manufacturing of the Polestar 3 in the U.S., expanding their existing production collaboration. For investors watching NasdaqGM:PSNY, these moves come against a backdrop of a share price at $18.42 and a long term track record that includes a 41.5% decline over the past...

Terex stock: context for recent performance Terex (TEX) has drawn fresh attention after recent share price moves, with the stock up 0.8% over the past day, showing a 14% decline over the past month and a 10.7% gain over the past 3 months. See our latest analysis for Terex. That 7.7% 1 day share price return sits against a 14.1% 30 day share price decline and a 57.4% 1 year total shareholder return, which suggests momentum has cooled recently after a strong run for longer term holders. If...

Eli Lilly (NYSE:LLY) agreed to acquire Centessa Pharmaceuticals in a deal valued at up to US$7.8b. The transaction would expand Lilly’s neuroscience portfolio and add orexin receptor agonist candidates for sleep disorders such as narcolepsy and hypersomnia. This is Lilly’s largest announced deal since 2019 and marks its entry into the sleep disorder therapeutics market. Eli Lilly is widely associated with diabetes and obesity treatments, and this move highlights a push to build a broader...

Wondering if Coeur Mining at around US$18.77 is still giving you fair value, or if the big moves are already priced in? This article breaks down what the current market price might be implying. The stock has produced a 236.4% return over the last year and 342.7% over 3 years, while more recently showing a 2.5% return over 7 days, a 30.9% decline over 30 days, and a 7.0% return year to date. This mix of results may signal changing expectations around risk and reward. Recent coverage has...

Weyerhaeuser recently drew investor attention ahead of its past Q1 2026 earnings release, as analysts projected a sharp year-over-year drop in funds from operations and weaker quarterly profit. At the same time, analysts’ expectations for stronger funds from operations and earnings per share in fiscal 2026 and 2027 have raised questions about how short-term pressure might contrast with the longer-term outlook for the timber REIT. Next, we’ll examine how the expected Q1 2026 profit drop and...

Natera, Inc. recently reported Clinical Cancer Research data showing its Signatera molecular residual disease test helped older women with early-stage ER+/HER2- breast cancer use primary endocrine therapy instead of surgery, with testing done at baseline and then every 3–6 months. The study’s ability to identify patients who remained progression-free and to detect molecular signs of tumor progression before imaging highlights Signatera’s potential role in personalized treatment decisions for...

Garmin (GRMN) is on investor radars after recent share price swings, with the stock up about 14% over the past 3 months but showing a decline over the past month alongside mixed short-term returns. See our latest analysis for Garmin. At a share price of $232.01, Garmin’s short term momentum has cooled, with a 30 day share price return decline of 8.23%, even as the 90 day share price return of 14.38% and 3 year total shareholder return of 145.35% point to stronger performance over a longer...

Carpenter Technology (CRS) is back on investors’ radar after recent share price moves, with the stock closing at $394.15. That level is drawing fresh interest in its long term return profile. See our latest analysis for Carpenter Technology. The recent 6.3% 1 day share price return sits against a quieter 30 day share price return and a stronger 90 day gain of 25.2%, while the 1 year total shareholder return is very large and the 3 and 5 year total shareholder returns are each more than 8x...

TMC the metals company Inc. recently filed multiple shelf registrations, including ESOP-related offerings totaling roughly 21.1 million common shares and a broader universal shelf covering common and preferred shares, debt, warrants and units, soon after reporting a full-year 2025 net loss of US$319.84 million. At the same time, TMC highlighted progress toward a U.S. commercial production permit, outlined plans for a large processing and refining hub at the Port of Brownsville in Texas, and...

Why Recursion Pharmaceuticals is on investors’ radar today Recursion Pharmaceuticals (RXRX) has attracted attention after recent trading, with the share price at $3.07 and returns showing mixed performance over the past week, month and past 3 months. For investors tracking high risk biotech names, the company’s clinical stage drug discovery pipeline, revenue of $74.681 million, and market cap of about $1.5b provide context for assessing whether the current level looks appealing or...

In the past quarter, TransDigm Group reported a 13.9% year-on-year revenue increase and exceeded analyst expectations on both sales and adjusted operating income, which management described as a solid start to its 2026 fiscal year. This performance highlights the breadth of TransDigm’s installed base, with its proprietary components touching nearly all in-service aircraft across commercial and military aviation. Next, we’ll examine how TransDigm’s stronger-than-expected revenue and operating...

If you are wondering whether Axon Enterprise at around US$424.69 still offers value or has run ahead of itself, you are not alone. The stock has recently seen a 7% decline over the last week, a 21.7% decline over the last month and a 24.6% decline year to date, even though the 1 year return sits at 21.5% and the 3 year and 5 year returns are 90.4% and 191.7% respectively. Recent headlines around Axon have focused on product rollouts, contract wins with law enforcement agencies and ongoing...

In late March 2026, Honeywell announced a multi-year supplier framework agreement with the U.S. Department of War to expand production of critical defense technologies, alongside a large debt tender and a new AI-powered video and access-control collaboration between Honeywell Building Automation and Rhombus initially focused on North America. Taken together, these moves highlight Honeywell’s push to modernize its balance sheet while deepening exposure to defense demand and cloud-based,...

Grab Holdings (GRAB) stock is drawing attention after the company and WeRide started public operations of the Ai.R autonomous ride service in Punggol, opening a new chapter for Grab’s mobility platform. See our latest analysis for Grab Holdings. Despite the Ai.R rollout and recent corporate updates, momentum in Grab Holdings' share price has been weak. The 30 day share price return is 12.44% and the year to date share price return is 27.95%, while the 1 year total shareholder return of 20.61%...

Dividend freeze and business shift put UPS in focus United Parcel Service (UPS) is back on investors’ radar after CFO Brian Dykes outlined a 2026 dividend freeze, along with a move away from a low-margin Amazon segment to target higher-value customers. See our latest analysis for United Parcel Service. UPS shares closed at US$98.38 after a 3.61% 1-day share price return. However, the 30-day share price return of 15.16% and 1-year total shareholder return decline of 3.80% show that recent...

Dollar Tree recently entered into a US$500 million term loan credit facility maturing in March 2029, with interest tied to the Term SOFR Rate plus 1.00%, flexible prepayment, and covenants linked to leverage and fixed charge coverage ratios. The new financing, combined with ongoing investment in rebuilt and newly acquired distribution centers and cloud-based supply chain technology, underscores management’s emphasis on upgrading infrastructure and inventory management capabilities. We’ll now...

Why Rumble’s CFO change matters for investors Rumble (RUM) is reshaping its senior team, bringing in former Intel executive Mike Masci as CFO on March 31, 2026, while outgoing CFO Brandon Alexandroff shifts into an advisor role. For you as an investor, this type of leadership change can affect how the company balances cash needs, growth investments, and potential capital allocation decisions, including its AI and cloud infrastructure plans. See our latest analysis for Rumble. Rumble’s latest...

In March 2026, Rambus Inc. insiders, including executives Seraphin Luc and John Shinn, sold more than US$4.60 million of stock, prompting renewed scrutiny of management’s intentions and timing. This wave of insider selling has become a focal point for investors already watching semiconductor sector weakness and questioning how closely leadership’s actions align with Rambus’s long-term positioning in AI-focused memory solutions. We’ll now examine how this recent insider selling flurry...